Rapid antigen test for simultaneous detection of influenza A & B and COVID-19 using advanced antigen-antibody technology. Delivers fast, reliable results for respiratory infection screening in clinical settings. ELISA and lateral flow formats available for point-of-care and laboratory use.
Manufactured by
ProGnosis Biotech S.A.
Larissa, Greece
ProGnosis Biotech, headquartered in Greece, is a global diagnostics provider with 11 subsidiaries and distributors in over 90 countries. The company offers a wide range of ELISA kits and lateral flow tests for the detection of mycotoxins, food allergens, antibiotic residues, GMOs, milk adulteration and histamine. It also provides hygiene monitoring solutions, including ATP detection and clinical diagnostics. ProGnosis Biotech also designs and produces proprietary antibodies, hardware and software, including an Android mobile app for instant report sharing.Committed to sustainable practices, it emphasizes green extraction methods and digital traceability, empowering safer food chains and protecting consumer health worldwide.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China · 1 relevant product
SureScreen Diagnostics Limited
United Kingdom · 4 relevant products
Beijing Jinwofu Bioengineering Technology Co.,Ltd.
China · 2 relevant products
76 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 114 closest product alternatives
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
Rapid immunochromatographic test for simultaneous detection of COVID-19 and influenza A/B antigens from respiratory specimens. Delivers results in 15-20 minutes, enabling quick differential diagnosis in clinical and point-of-care settings. Single-use test cassette with high sensitivity and specificity for viral antigen identification.
SureScreen Diagnostics Limited · United Kingdom
A rapid diagnostic test that delivers simultaneous results for both COVID-19 and influenza viruses, helping clinicians make informed decisions and patients receive appropriate care quickly.
Beijing Jinwofu Bioengineering Technology Co.,Ltd. · China
A rapid antigen test kit for simultaneous detection of Influenza A, Influenza B, and COVID-19 (SARS-CoV-2). This combo test enables efficient screening for multiple respiratory viruses in a single procedure.
111 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products